Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis

Summary

This is an observational ambispective cohort study to validate the Baveno VI guideline and develop a new diagnostic model to screen high-risk varices (HRV) of liver cirrhosis using iLivTouch.

Conditions

• Varices
• Liver Cirrhosis

Interventions

DIAGNOSTIC_TEST

different diagnostic models

the patients were screened by different diagnostic models

Sponsors & Collaborators

• Qianfoshan Hospital

  collaborator OTHER

• First Hospital of China Medical University

  collaborator OTHER

• The Second Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• Second Hospital of Jilin University

  collaborator OTHER

• Shengjing Hospital

  collaborator OTHER

• The Affiliated Hospital Of Guizhou Medical University

  collaborator OTHER

• The First Hospital of Yulin

  collaborator UNKNOWN

• LanZhou University

  collaborator OTHER

• Chengdu Third People's Hospital

  collaborator UNKNOWN

• Tianjin Third Central Hospital

  collaborator OTHER

• Second Affiliated Hospital of Xi'an Jiaotong University

  collaborator OTHER

• People's Hospital of Lixin County

  collaborator UNKNOWN

• The Fourth People's Hospital of Qinghai Province

  collaborator OTHER

• The Fourth People's Hospital of Nanning

  collaborator OTHER

• The Third People's Hospital of Taiyuan

  collaborator OTHER

• Central Hospital of Huludao

  collaborator UNKNOWN

• Jixi Infectious Diseases Hospital

  collaborator UNKNOWN

• the first affiliated hospital of Jiamusi university

  collaborator UNKNOWN

• Benxi Sixth People's Hospital

  collaborator UNKNOWN

• Yuncheng Central Hospital

  collaborator OTHER

• The First People's Hospital of Zigong City, Sichuan Province

  collaborator UNKNOWN

• Second Affiliated Hospital of Guangzhou Medical University

  collaborator OTHER

• Ruikang Affiliated Hospital of Guangxi University of Chinese Medicine

  collaborator UNKNOWN

• Guilin People's Hospital

  collaborator UNKNOWN

• Tianjin Binhai New Area Dagang Hospital

  collaborator UNKNOWN

• Beijing 302 Hospital

  lead OTHER

Principal Investigators

• Fu junliang · the Fifth Medical Center, Chinese PLA General Hospital

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-11-30

Primary Completion

2025-06-30

Completion

2025-12-31

Countries

• China

Study Locations